Embedded Files
CJC-1295 NO DAC / IPAMORELIN (5MG/5MG)
WHAT IT IS
CJC-1295 No DAC and Ipamorelin are commonly paired growth hormone secretagogue peptides used to stimulate natural growth hormone (GH) release.
CJC-1295 No DAC is a short-acting GHRH analog that promotes pulsatile GH release similar to the body’s natural secretion pattern.
Ipamorelin is a selective ghrelin receptor agonist (GHRP) that further enhances GH release while having minimal impact on cortisol and prolactin levels.
When combined, they work synergistically to support recovery, body composition, and sleep.
COMMON BENEFITS
• Supports fat metabolism and lipolysis
• Helps preserve and support lean muscle mass
• Supports recovery from training and tissue stress
• May improve tendon, ligament, and connective tissue repair
• Supports collagen production and skin elasticity
• Commonly used in anti-aging and recovery-focused protocols
• May improve sleep quality
• May support recovery, mood, and energy levels
━━━━━━━━━━━━━━━━━━
CJC-1295 DAC VS NO DAC
━━━━━━━━━━━━━━━━━━
CJC-1295 with DAC:
• Long half-life (up to 6-8 days)
• Sustained GH elevation
• Less frequent injections
• Higher risk of desensitization with prolonged use
CJC-1295 No DAC:
• Short half-life (~30 minutes)
• Produces natural GH pulses lasting 2-3 hours
• Usually dosed more frequently
• Lower risk of desensitization
━━━━━━━━━━━━━━━━━━
POSSIBLE SIDE EFFECTS
━━━━━━━━━━━━━━━━━━
• Injection site irritation
• Water retention
• Bloating
• Mild fatigue or lethargy
• Headaches
• Flushing or warm sensation after injection
• Increased hunger
• Nausea
• Dry mouth
• Tingling or numbness
• Joint stiffness or discomfort
• Dizziness or lightheadedness
Rare:
• Allergic reactions
• Difficulty breathing
• Excessive GH-like symptoms with prolonged misuse
━━━━━━━━━━━━━━━━━━
INTERACTIONS
━━━━━━━━━━━━━━━━━━
• May affect insulin sensitivity and blood sugar regulation
• Use caution with insulin or antidiabetic medications
• Thyroid medications may require monitoring
• Corticosteroids may reduce effectiveness
• May increase fluid retention in some individuals
• Use caution with blood pressure medications
• Estrogen may reduce IGF-1 response
• May have additive effects with testosterone, SARMs, anabolic agents, or hormone therapies
• Alcohol, sedatives, and sleep medications may worsen dizziness or fatigue
━━━━━━━━━━━━━━━━━━
CONTRAINDICATIONS
━━━━━━━━━━━━━━━━━━
Do not use if:
• Pregnant or breastfeeding
• You have active cancer
• You have untreated hypothyroidism
• You have uncontrolled diabetes
• You have elevated GH/IGF-1 levels or acromegaly
• You have advanced kidney disease
• You have unstable thyroid disease
• You are critically ill
• You are allergic to peptide components or mannitol
━━━━━━━━━━━━━━━━━━
DOSING & ADMINISTRATION
━━━━━━━━━━━━━━━━━━
Cycle Length
• 12-16 week cycle
• Followed by 8-16 week washout period
Administration
• Subcutaneous injection
• 1x daily
• Best administered before bedtime while fasted for 2+ hours
• May also be used upon waking before breakfast
Important Notes
• Inject slowly to reduce flushing or pins-and-needles sensation
• Avoid eating immediately after dosing
━━━━━━━━━━━━━━━━━━
RECONSTITUTION
━━━━━━━━━━━━━━━━━━
Mix with:
• 2.5mL (250 units) BAC water
STANDARD PROTOCOL
Dose:
• 6-15 units
• 1x daily
• 5-7 days/week
Starting dose:
• Begin with 6 units daily
• Slowly titrate upward if needed
MAXIMUM PROTOCOL
Dose:
• 12-30 units
• 1x daily
• 5-7 days/week
Starting dose:
• Begin with 12 units daily
• Slowly titrate upward if needed
━━━━━━━━━━━━━━━━━━
SYNERGISTIC STACKS
━━━━━━━━━━━━━━━━━━
• L-Carnitine → supports fat metabolism and energy utilization
• AOD-9604 → additional lipolysis support
• BPC-157 / TB-500 → connective tissue and recovery support
━━━━━━━━━━━━━━━━━━
IMPORTANT NOTES
━━━━━━━━━━━━━━━━━━
• Always double check peptide calculations before administration
• Responses vary from person to person
• Proper sleep, nutrition, and training heavily influence results
• Store according to peptide storage guidelines
Report abuse